Stockholm April 7, 2020:
A research study has started with one thousand randomely citizens of Stockholm, in Sweden, doing home sampling using Capitainer for Covid-19 immunity
The Capitainer qDBS solution is designed to enable convenient and quantitative blood sampling at the fingertip.
KTH, the Royal Institute of Technology, has started a research study for home sampling using Capitainer as the device. The study is based on home sampling to be sent in for analyze at a laboratory for verification of Covid-19 immunity.
Some of the published news, TV-spots as of 2020-04-07, see below links.
News in English:
https://www.kth.se/en/aktuellt/nyheter/1-000-stockholmare-testas-for-corona-i-pask-1.973722
National public service and news:
https://www.svt.se/nyheter/vetenskap/forhoppningen-tester-av-
immunitet-kan-komma-igang-redan-nasta-vecka
https://www.tv4play.se/program/nyheterna/12580156
https://www.expressen.se/nyheter/coronaviruset/tusen-stockholmare-kan-testas-for-corona-i-hemmet/
